Physician profile
Stanley E Potocki
NPI 1548209810
$3,918.35
in general payments reported to CMS, 2019-2025
12 companies · $346 in 2025
The $346 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,312 · 2020: $407 · 2021: $169 · 2022: $291 · 2023: $170 · 2024: $223 · 2025: $346.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $705 · Education: $34.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $704.90 |
| Education | $34.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,494.45 | 2019-2024 | Scopis Ent |
| Acclarent, INC | $350.18 | 2019-2022 | |
| Medtronic, INC. | $216.39 | 2024-2025 | Stealthstation S8 Platform, Novapak, Propel |
| Glaxosmithkline, LLC. | $183.39 | 2022-2025 | Nucala |
| Genzyme Corporation | $176.33 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $139.58 | 2019-2023 | Dupixent |
| Integra Lifesciences Corporation | $121.79 | 2023-2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Amgen INC. | $80.97 | 2025 | Tezspire |
| Intersect Ent, INC. | $61.17 | 2019 | |
| Kaleo, INC. | $49.76 | 2019-2020 | |
| Baxter Healthcare | $23.31 | 2024 | Floseal |
| Arbor Pharmaceuticals, INC. | $21.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stanley Potocki listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.